Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.
about
miRNAs Participate in MS Pathological Processes and Its Therapeutic ResponseEpigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug ResponseElusive roles for reactive astrocytes in neurodegenerative diseasesMicroRNA (miRNA): sequence and stability, viroid-like properties, and disease association in the CNSUp-Regulation of miRNA-146a in Progressive, Age-Related Inflammatory Neurodegenerative Disorders of the Human CNSIL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy ResistanceExtrinsic and Intrinsic Regulation of Axon Regeneration by MicroRNAs after Spinal Cord InjuryIncreased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitusEvolution of microRNA (miRNA) Structure and Function in Plants and Animals: Relevance to Aging and DiseaseGenomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cellsRNA metabolism in neurodegenerative disease.Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34aDietary methanol regulates human gene activityThe epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response.Epigenomics of Alzheimer's disease.miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cellsDecreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patientsAnalysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosismicroRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients.Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.Identification of endogenous reference genes for the analysis of microRNA expression in the hippocampus of the pilocarpine-induced model of mesial temporal lobe epilepsyDifferential expression and clinical significance of three inflammation-related microRNAs in gangliogliomasmiRNA-155 upregulation and complement factor H deficits in Down's syndrome.Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD)Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures.microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular DegenerationIncreased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesityAmyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).Evolution and complexity of micro RNA in the human brainEvidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment.MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological FeaturesStudy on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D.microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.MicroRNA dysregulation in multiple sclerosis.
P2860
Q26748774-77243C33-1262-44BE-860F-6A93931049BDQ26772028-3072AC69-9751-4666-8760-23D60311E0B8Q26797399-B604A271-9D22-4769-A9F3-42EC320A3A59Q26825514-DBAD1B7D-E03B-4A8F-9CBE-350AC4F3FF07Q26851364-9AEB7047-F244-4B08-9AFF-CD2C79E52C9AQ26866390-BB76E13B-7DFD-4F34-8548-5ADB88BFB8FBQ28070238-2140C6D1-1BD7-4DC7-B251-042B53E3D73DQ28536498-A92A9E3F-982F-48B0-AA58-1EF6DEDA7037Q28647645-9E024E80-B192-40C4-945D-7131C6AA0F2AQ33637672-C89813DA-842E-40DF-95C8-DBA2363D19CEQ33686370-B6398388-7BBA-4F99-8D3A-CEB08F00177BQ33746283-B6AC2DA4-F85F-4F93-A15A-646D54C01D9AQ33810922-4266421A-6345-406E-9F4F-24994CC659C3Q33916628-10059776-F199-4891-9272-9EBDE4188A51Q34426210-BEDCCA3E-8B0F-4694-A9BA-8BC062554D5EQ34427432-B017739F-5E62-48F9-8B67-E5CE6F7C1736Q34518584-A8052382-B9F3-4BAC-AB27-03DA7E9FB7CAQ34653749-0E0EA566-5EA5-47A3-BD7F-2AD00622B236Q34690982-A99A5502-2BAC-4462-8881-8E441E884E9BQ34788620-726AA9F5-EA49-4601-8E2F-35A3850CCC0EQ35078869-9C03B94A-1EB9-423D-91E0-4F2E4B0AEE3FQ35106556-7714C1F8-234D-47F2-970B-891170920800Q35111407-C69038C4-FEE2-41B1-AE5E-104CC5C7D209Q35194710-25FE8FA8-7D01-4AE8-B58D-0D05162D681CQ35655451-17EB2BCE-729A-4A7D-8C1C-B02F8909C949Q35690949-64916211-ABBF-4A42-B802-429F3A24BC94Q35742846-F1368B48-225B-44F0-9D3F-D93072BFE872Q35874830-2EC0FE0F-770D-47D2-8A3C-9E09F9118297Q35887465-1DE1937B-252F-4395-AFC3-CCF7DC88B251Q35929293-54705D0F-9C37-4B6C-AF22-2031C26B6A42Q35947548-595607CE-6D9B-4C5F-AB77-01922C67EBD5Q35996863-53E5B3DB-B068-4AB9-9941-7402F9655EEDQ36103515-1E79C789-7E3F-4652-A85C-40F13C8860A5Q36204358-3CA15D71-AF15-476A-974F-F872890B1995Q36249445-763EB8EC-CFF9-43B9-879A-CD841486BCE8Q36404334-2FA6064C-1D5E-4976-8861-6591DB75965FQ36466672-53CB6F14-B62A-4145-AC04-47BDA7A05170Q36499038-DB2C6997-A26B-44CD-AAED-E76458A42F96Q36540471-9E43E4A7-CB5C-48AD-B5B6-C720398A14AFQ36551019-25B4F7AF-95F7-4C6C-B6D5-A5FE3A915EB3
P2860
Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differential regulation of int ...... ells and in Alzheimer disease.
@ast
Differential regulation of int ...... ells and in Alzheimer disease.
@en
Differential regulation of interleukin-1 receptor-associated kinase-1
@nl
type
label
Differential regulation of int ...... ells and in Alzheimer disease.
@ast
Differential regulation of int ...... ells and in Alzheimer disease.
@en
Differential regulation of interleukin-1 receptor-associated kinase-1
@nl
prefLabel
Differential regulation of int ...... ells and in Alzheimer disease.
@ast
Differential regulation of int ...... ells and in Alzheimer disease.
@en
Differential regulation of interleukin-1 receptor-associated kinase-1
@nl
P2093
P2860
P921
P356
P1476
Differential regulation of int ...... cells and in Alzheimer disease
@en
P2093
Jian Guo Cui
Walter J Lukiw
Yuan Yuan Li
Yuhai Zhao
P2860
P304
38951-38960
P356
10.1074/JBC.M110.178848
P407
P577
2010-10-11T00:00:00Z